Strides Arcolab shares up 4% on Sun Pharma deal
Shares of Strides Arcolab rose by 4 percent Monday as it entered into a pact with Sun Pharma to buy from it erstwhile Ranbaxy's two divisions in central nervous system (CNS) segment in India for Rs 165 crore.
Sep 21, 2015, 13:27 PM IST